Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: A Japanese Gynecologic Oncology Group study (JGOG2041)

  • H. Nomura
  • , D. Aoki
  • , F. Takahashi
  • , N. Katsumata
  • , Y. Watanabe
  • , I. Konishi
  • , T. Jobo
  • , M. Hatae
  • , M. Hiura
  • , N. Yaegashi

Research output: Contribution to journal › Article › peer-review

76 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: A Japanese Gynecologic Oncology Group study (JGOG2041)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases